MXPA02006030A - Lipopeptidos como agentes antibacterianos. - Google Patents
Lipopeptidos como agentes antibacterianos.Info
- Publication number
- MXPA02006030A MXPA02006030A MXPA02006030A MXPA02006030A MXPA02006030A MX PA02006030 A MXPA02006030 A MX PA02006030A MX PA02006030 A MXPA02006030 A MX PA02006030A MX PA02006030 A MXPA02006030 A MX PA02006030A MX PA02006030 A MXPA02006030 A MX PA02006030A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- lipopeptides
- antibacterial agents
- relates
- producing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
La presente invencion se relaciona con compuestos lipopeptidicos novedosos. La invencion tambien se relaciona con composiciones farmaceuticas de estos compuestos y los metodos para utilizar estos compuestos como compuestos antibacterianos. La invencion tambien se relaciona con los metodos para producir estos compuestos lipopeptidicos novedosos y los intermediarios utilizados para producir estos compuestos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17094699P | 1999-12-15 | 1999-12-15 | |
US20822200P | 2000-05-30 | 2000-05-30 | |
PCT/US2000/034205 WO2001044274A1 (en) | 1999-12-15 | 2000-12-15 | Lipopeptides as antibacterial agents |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02006030A true MXPA02006030A (es) | 2004-08-23 |
Family
ID=26866577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02006030A MXPA02006030A (es) | 1999-12-15 | 2000-12-15 | Lipopeptidos como agentes antibacterianos. |
Country Status (12)
Country | Link |
---|---|
US (3) | US7408025B2 (es) |
EP (1) | EP1246838A1 (es) |
JP (1) | JP2003517480A (es) |
KR (1) | KR20020063228A (es) |
CN (1) | CN1423656A (es) |
AU (1) | AU784812B2 (es) |
BR (1) | BR0016467A (es) |
CA (1) | CA2394350A1 (es) |
IL (1) | IL150225A0 (es) |
MX (1) | MXPA02006030A (es) |
NO (1) | NO20022887L (es) |
WO (1) | WO2001044274A1 (es) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6696412B1 (en) | 2000-01-20 | 2004-02-24 | Cubist Pharmaceuticals, Inc. | High purity lipopeptides, Lipopeptide micelles and processes for preparing same |
US6511962B1 (en) * | 2000-07-17 | 2003-01-28 | Micrologix Biotech Inc. | Derivatives of laspartomycin and preparation and use thereof |
ES2377931T5 (es) | 2000-12-18 | 2015-11-04 | Cubist Pharmaceuticals, Inc. | Métodos para preparar lipopéptidos purificados |
US20060014674A1 (en) | 2000-12-18 | 2006-01-19 | Dennis Keith | Methods for preparing purified lipopeptides |
EP1423414A4 (en) * | 2001-08-06 | 2005-11-30 | Cubist Pharm Inc | NEW DEPSIPEPTIDES AND METHOD FOR THE PRODUCTION THEREOF |
EP1932853A1 (en) | 2001-08-06 | 2008-06-18 | Cubist Pharmaceutical Inc. | Novel depsipeptides and process for preparing same |
US6767718B2 (en) | 2002-05-10 | 2004-07-27 | Biosource Pharm, Inc. | Lipodepsipeptide antibiotics and methods of preparation |
US7317001B2 (en) | 2002-06-06 | 2008-01-08 | Oscient Pharmaceuticals Corporation | Use of ramoplanin to treat diseases associated with the use of antibiotics |
US7521560B2 (en) * | 2004-06-29 | 2009-04-21 | Rigel Pharmaceuticals, Inc. | 2-substituted quinoline compounds and their uses |
US20060004185A1 (en) | 2004-07-01 | 2006-01-05 | Leese Richard A | Peptide antibiotics and peptide intermediates for their prepartion |
FR2874922A1 (fr) * | 2004-07-30 | 2006-03-10 | Palumed Sa | Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien |
BRPI0514381A (pt) * | 2004-07-30 | 2008-06-10 | Palumed Sa | compostos hìbridos de aminoquinolina-antibiótico, composições farmacêuticas, método de preparação e uso destes |
CA2587848A1 (en) * | 2004-11-12 | 2006-10-19 | Cubist Pharmaceuticals, Inc. | Antiinfective lipopeptides |
US8968781B2 (en) | 2005-04-29 | 2015-03-03 | Cubist Pharmaceuticals, Inc. | Therapeutic compositions |
US7964729B2 (en) | 2006-08-28 | 2011-06-21 | Massachusetts Institute Of Technology | Sox-based kinase sensor |
US8440835B2 (en) | 2007-02-26 | 2013-05-14 | Massachusetts Institute Of Technology | Environmentally sensitive fluorophores |
EP2018864A1 (en) | 2007-07-23 | 2009-01-28 | Biomet Deutschland GmbH | Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition |
PT2379580E (pt) * | 2008-12-22 | 2014-01-20 | Cubist Pharm Inc | Novos agentes antibacterianos para o tratamento de infecções por bactérias gram positivas |
TW201035111A (en) | 2008-12-23 | 2010-10-01 | Biosource Pharm Inc | Antibiotic compositions for the treatment of gram negative infections |
WO2011025546A1 (en) | 2009-08-31 | 2011-03-03 | Massachusetts Institute Of Technology | 1, 2, 3-triazole containing protein kinase sensors |
MX2012005993A (es) | 2009-11-23 | 2012-11-23 | Cubist Pharm Inc | Composiciones de lipopeptido y metodos relacionados. |
US8415307B1 (en) | 2010-06-23 | 2013-04-09 | Biosource Pharm, Inc. | Antibiotic compositions for the treatment of gram negative infections |
WO2012011917A1 (en) * | 2010-07-23 | 2012-01-26 | Activbiotics Pharma, Llc | Administration of rifalazil to immunocompromised patients |
US8609672B2 (en) | 2010-08-27 | 2013-12-17 | University Of The Pacific | Piperazinylpyrimidine analogues as protein kinase inhibitors |
US20120317234A1 (en) * | 2011-06-09 | 2012-12-13 | International Business Machines Corporation | Managing data access in mobile devices |
WO2013059610A1 (en) | 2011-10-20 | 2013-04-25 | Trius Therapeutics, Inc. | Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use |
US9165332B2 (en) * | 2012-01-27 | 2015-10-20 | Microsoft Technology Licensing, Llc | Application licensing using multiple forms of licensing |
US9348608B2 (en) * | 2013-04-24 | 2016-05-24 | QRC, Inc. | System and method for registering application and application transforms on a radiofrequency digitization and collection device |
EP3004892B1 (en) * | 2013-05-24 | 2018-10-10 | Nestec S.A. | Method for diagnosing irritable bowel syndrome |
CN104322562B (zh) * | 2014-09-16 | 2017-04-26 | 南京农业大学 | 一种脂肽‑高岭土复合生防制剂及其制备方法和应用 |
US10647746B2 (en) * | 2016-04-08 | 2020-05-12 | Versitech Limited | Antibacterial cyclic lipopeptides |
US11667674B2 (en) | 2016-04-08 | 2023-06-06 | Versitech Limited | Antibacterial cyclic lipopeptides |
US20200157144A1 (en) * | 2017-08-01 | 2020-05-21 | Agency For Science, Technology And Research | Antimicrobial peptidomimetics |
CA3170514A1 (en) | 2020-03-12 | 2021-09-16 | Baxter International Inc. | Daptomycin formulations containing a combination of sorbitol and mannitol |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4399067A (en) * | 1982-05-21 | 1983-08-16 | Eli Lilly And Company | Derivatives of A-21978C cyclic peptides |
US4482487A (en) * | 1982-05-21 | 1984-11-13 | Eli Lilly And Company | A-21978C cyclic peptides |
US4524135A (en) * | 1982-05-21 | 1985-06-18 | Eli Lilly And Company | A-21978C cyclic peptides |
US4537717A (en) * | 1982-05-21 | 1985-08-27 | Eli Lilly And Company | Derivatives of A-21978C cyclic peptides |
IL68700A0 (en) * | 1982-05-21 | 1983-09-30 | Lilly Co Eli | Improvements relating to a-21978c cyclic peptide derivatives and their production |
US4396543A (en) * | 1982-05-21 | 1983-08-02 | Eli Lilly And Company | Derivatives of A-21978C cyclic peptides |
USRE32310E (en) | 1982-05-21 | 1986-12-16 | Eli Lilly And Company | Derivatives of A-21978C cyclic peptides |
USRE32311E (en) | 1982-05-21 | 1986-12-16 | Eli Lilly And Company | Derivatives of A-21978C cyclic peptides |
CN1013120B (zh) | 1984-10-09 | 1991-07-10 | 伊莱利利公司 | A-21978c衍生物生产方法改进 |
CA1315229C (en) | 1987-06-10 | 1993-03-30 | Patrick J. Baker | Chromatographic purification process |
EP0460882B1 (en) * | 1990-06-07 | 1996-07-24 | Eli Lilly And Company | Lipopeptide deacylase |
DE4411025A1 (de) | 1994-03-30 | 1995-10-05 | Hoechst Ag | Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung |
KR100545506B1 (ko) | 1996-03-08 | 2006-10-04 | 아스테라스 세이야쿠 가부시키가이샤 | 환상 리포펩티드 물질의 탈아실화 방법 |
DE19807972A1 (de) | 1998-02-25 | 1999-08-26 | Hoechst Marion Roussel De Gmbh | Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung |
AU784942B2 (en) * | 1999-12-15 | 2006-08-03 | Cubist Pharmaceuticals, Inc. | Daptomycin analogs and their use as antibacterial agents |
KR20020063227A (ko) * | 1999-12-15 | 2002-08-01 | 큐비스트 파마슈티컬즈 인코포레이티드 | 항균제로서 신규한 리포펩티드 |
-
2000
- 2000-12-15 US US09/737,908 patent/US7408025B2/en not_active Expired - Lifetime
- 2000-12-15 AU AU36357/01A patent/AU784812B2/en not_active Expired
- 2000-12-15 BR BR0016467-4A patent/BR0016467A/pt not_active IP Right Cessation
- 2000-12-15 WO PCT/US2000/034205 patent/WO2001044274A1/en active IP Right Grant
- 2000-12-15 JP JP2001544763A patent/JP2003517480A/ja not_active Withdrawn
- 2000-12-15 EP EP00991867A patent/EP1246838A1/en not_active Withdrawn
- 2000-12-15 CN CN00818430A patent/CN1423656A/zh active Pending
- 2000-12-15 CA CA002394350A patent/CA2394350A1/en not_active Abandoned
- 2000-12-15 MX MXPA02006030A patent/MXPA02006030A/es not_active Application Discontinuation
- 2000-12-15 IL IL15022500A patent/IL150225A0/xx unknown
- 2000-12-15 KR KR1020027007681A patent/KR20020063228A/ko not_active Application Discontinuation
-
2002
- 2002-06-17 NO NO20022887A patent/NO20022887L/no not_active Application Discontinuation
-
2008
- 2008-06-27 US US12/163,225 patent/US20090011977A1/en not_active Abandoned
- 2008-06-27 US US12/163,299 patent/US20080287347A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU784812B2 (en) | 2006-06-29 |
AU3635701A (en) | 2001-06-25 |
US7408025B2 (en) | 2008-08-05 |
WO2001044274A1 (en) | 2001-06-21 |
IL150225A0 (en) | 2002-12-01 |
US20090011977A1 (en) | 2009-01-08 |
CN1423656A (zh) | 2003-06-11 |
NO20022887L (no) | 2002-08-12 |
EP1246838A1 (en) | 2002-10-09 |
BR0016467A (pt) | 2002-08-27 |
US20040067878A1 (en) | 2004-04-08 |
NO20022887D0 (no) | 2002-06-17 |
KR20020063228A (ko) | 2002-08-01 |
JP2003517480A (ja) | 2003-05-27 |
CA2394350A1 (en) | 2001-06-21 |
US20080287347A1 (en) | 2008-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA02006029A (es) | Lipopeptidos novedosos como agentes antibacterianos. | |
MXPA02006030A (es) | Lipopeptidos como agentes antibacterianos. | |
MXPA02006028A (es) | Lipopeptidos novedosos como agentes antibacterianos. | |
AU2002319814A1 (en) | Substituted 1h-dihydropyrazoles, their preparation and use | |
EE200100485A (et) | Uudsed ühendid ja kompositsioonid proteaasi inhibiitoritena | |
DE60038183D1 (de) | Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe | |
PL358281A1 (en) | Novel compounds | |
EP1423137A4 (en) | STEREO-ISOMERS OF LIPOPEPTIDE, METHODS OF PREPARATION AND USEFUL INTERMEDIATES | |
MXPA02007942A (es) | Derivados de pirrolopirimidinona, procesos de preparacion y uso. | |
AU3227700A (en) | Skin sanitizing compositions | |
DE60033649D1 (de) | Verbindungen und therapeutische methoden | |
MXPA03007857A (es) | Compuestos y composiciones para entregar agentes activos. | |
SE9901077D0 (sv) | Novel use | |
DE50113345D1 (de) | Arginin-mimetika als faktor xa-inhibitoren | |
MXPA02010458A (es) | Peptido modulador del receptor de trombopoyetina. | |
MXPA04002282A (es) | Nuevos compuestos y preparaciones como inhibidores de la catepsina. | |
AU4011300A (en) | Compositions and methods for the treatment of immune related diseases | |
MXPA04001773A (es) | Derivados de 6,7-dihidroxitetrahidroisquinolinas 3-sustituidas parta uso como agentes antibacterianos. | |
PL328225A1 (en) | Diphenylstilbenes as pro-medications used to produce cox-2-inhibitors | |
WO2006110185A3 (en) | Antiinfective lipopeptides | |
EP1303300A4 (en) | COMPOSITIONS AND METHODS FOR TREATING CANDIDIASIS | |
IL150979A0 (en) | 9-alkylamino-1-nitroacridine derivatives | |
DE60212101D1 (de) | Alanin-2,6-dialkoxyphenylesterderivate als hypnotika | |
HUP0400007A2 (hu) | Alkanoil-L-karnitin alkalmazása anhedónia kezelésére szolgáló gyógyászati készítmény előállítására | |
MXPA05003633A (es) | 2"-oxo-voruscharina y derivados de la misma. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |